drugset / Trial / NCT05316922

TSH Suppression During Radiotherapy on Thyroid Site to Prevent Iatrogenic Hypothyroidism in Pediatric Cancer Patients

NCT05316922

RandomizedParallel-groupOpen-labelPrevention

Summary

To offer the possibility of a treatment that could achieve a meaningful reduction in the incidence of post-radiation therapy hypothyroidism. Thyroid dysfunction may develop from a few months to several years after patients have completed their radiation treatment. In children with chronic diseases, or given lengthy anti-neoplastic treatments, recurrent or persistent endocrine disorders may have a negative effect on growth and development into adulthood.

Timeline

Start
2021-12-13
Primary completion
2029-09-30
Completion
2029-09-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Levothyroxine Other / unclassified

Indications